Steven Messe, MD
Vascular Neurology · Philadelphia, PANPI 1174557888
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,915 of the $14,256 with a category attached, or 90.6%. Bolton Medical Inc accounts for 70.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $8,530 and has fallen 63.6% since, to $3,109 in 2025. Among vascular neurology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $339.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bolton Medical Inc$10K
- Novartis$3K
- Boston Scientific$527
- Medtronic$287
- Biogen$157
- Abiomed$127
- plus $92 from 3 others
Across 18 payments — averaging $16,705 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$142K
- Novartis$97K
- Mallinckrodt Enterprises LLC$43K
- Mallinckrodt Hospital Products Inc.$16K
- W. L. Gore & Associates, Inc.$1K
- Novo Nordisk AS$1K
- plus $88 from 1 others
What the payments were for
- Consulting fees$12,91591%
- Travel & lodging$3703%
- Food & beverage$9717%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bolton Medical Inc | 26 | $10,051 |
| Novartis | 3 | $3,015 |
| Boston Scientific | 2 | $527 |
| Medtronic(2 entities) | 3 | $287 |
| Biogen | 3 | $157 |
| Abiomed | 1 | $127 |
| Philips North America LLC | 2 | $43 |
| Ceribell, Inc. | 1 | $26 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Grafts$7,540
- Relay Grafts$2,175
- GENERAL - THERAPIES$527
- STENTS$300
- LINQ II$203
- Impella$127
How this compares
$14,256 in reported general payments places this provider in the 90th percentile of 52 vascular neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 58 | $43,589 |
| XareltoRivaroxaban | 29 | $27,384 |
| Icosapent Ethyl | 21 | $6,824 |
| Gabapentin | 13 | $711 |
| Levetiracetam | 21 | $591 |
| Memantine Hcl | 19 | $379 |
| ClopidogrelClopidogrel Bisulfate | 28 | $238 |
| Ezetimibe | 11 | $181 |
| Atorvastatin Calcium | 18 | $140 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Philadelphia
- Scott KasnerPhiladelphia$210K
- Michael McGarveyPhiladelphia$15K
- Donna GeorgePhiladelphia$4K
- Brett CucchiaraPhiladelphia$2K
- Sydni ColePhiladelphia$408
- Paul NovelloPhiladelphia$122
- Christopher FavillaPhiladelphia$109
- Kelley HumbertPhiladelphia$85
- Qingyang YuanPhiladelphia$79
- Laura SteinPhiladelphia$64
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.